EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Antifungal treatment strategies in intensive care unit patients

Claudia Bartalucci, Laura Mezzogori, Riccardo Schiavoni, Antonio Vena, Daniele Roberto Giacobbe, Matteo Bassetti

European Journal of Clinical Investigation · 2026-01 · 56 (1)

DOI: 10.1111/eci.70177 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 22.01.2026. Verfasst von Claudia Bartalucci und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy. Hauptthemen laut MEDLINE: Antifungal Agents, Pneumonia, Pneumocystis, Invasive Fungal Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 103 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Invasive fungal infections (IFIs) are a major cause of morbidity and mortality among critically ill patients. In the intensive care unit (ICU), invasive candidiasis (IC), invasive pulmonary aspergillosis (IPA), and Pneumocystis jirovecii pneumonia (PjP) represent the most prevalent and clinically relevant fungal diseases. Their diagnosis is often hampered by nonspecific clinical and radiological findings, delayed or negative cultures, and suboptimal performance of fungal biomarkers in this population. As a result, antifungal treatment strategies in the ICU must balance the need for early initiation with the risk of overtreatment and resistance.

Methods

This review summarizes current therapeutic approaches, evidence‐based recommendations, and recent advances for the treatment of IC, IPA, and PjP in critically ill patients. Pharmacokinetic/pharmacodynamic (PK/PD) considerations, therapeutic drug monitoring, and emerging antifungal agents are also discussed.

Results

For IC, echinocandins remain the cornerstone of therapy, while biomarker‐guided strategies appear more useful for treatment discontinuation than initiation. In IPA, voriconazole and isavuconazole are first‐line agents, with liposomal amphotericin B as an alternative in case of azole resistance or intolerance; the role of combination therapy remains uncertain. For PjP, trimethoprim–sulfamethoxazole is the treatment of choice, while adjunctive corticosteroids are recommended mainly for people with HIV and severe disease. Emerging antifungal agents, including rezafungin, fosmanogepix, and olorofim, may enhance future treatment options.

Conclusions

Optimizing antifungal stewardship through individualized therapy and early diagnosis remains essential to improve outcomes in this high‐risk population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsPneumonia, PneumocystisInvasive Fungal InfectionsHumansIntensive Care UnitsCandidiasis, InvasiveCritical IllnessInvasive Pulmonary AspergillosisEchinocandinsVoriconazoleAmphotericin BTriazolesPyridinesNitriles

Stichwörter der Autor:innen

antifungal stewardshipcritically ill patientsintensive care unitinvasive fungal infections

Substanzen

Antifungal AgentsEchinocandinsVoriconazoleAmphotericin BTriazolesisavuconazolePyridinesliposomal amphotericin BNitriles

Autor:innen und Institutionen

  • Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
  • UO Clinica Malattie Infettive, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Zitieren

APA

Bartalucci, C., Mezzogori, L., Schiavoni, R., Vena, A., Giacobbe, D. R., & Bassetti, M. (2026). Antifungal treatment strategies in intensive care unit patients. European Journal of Clinical Investigation, 56(1). https://doi.org/10.1111/eci.70177

Vancouver

Bartalucci C, Mezzogori L, Schiavoni R, Vena A, Giacobbe DR, Bassetti M. Antifungal treatment strategies in intensive care unit patients. European Journal of Clinical Investigation. 2026;56(1). doi:10.1111/eci.70177

BibTeX
@article{Bartalucci2026,
  author = {Bartalucci, Claudia and Mezzogori, Laura and Schiavoni, Riccardo and Vena, Antonio and Giacobbe, Daniele Roberto and Bassetti, Matteo},
  title = {Antifungal treatment strategies in intensive care unit patients},
  journal = {European Journal of Clinical Investigation},
  year = {2026},
  volume = {56},
  number = {1},
  doi = {10.1111/eci.70177}
}
Kostenlos starten →